BDX (Becton Dickinson) Other Current Receivables: $0 Mil (As of Mar. 2026)


BDX Becton Dickinson & Co BDX
76 GF Score
Price $151.38
GF Value $191.05
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Other Current Receivables?

Becton Dickinson BDX +2.44% 76 Other Current Receivables is $0 Mil as of Mar. 2026. GuruFocus rates BDX with a GF Score™ of 76/100 and a GF Value™ of $191.05 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Becton Dickinson's Other Current Receivables for the quarter that ended in Mar. 2026 was $0 Mil.

Becton Dickinson Other Current Receivables Related Terms

Becton Dickinson Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Other Current Receivables Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BDX
76GF Score
Becton Dickinson & Co BDX
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0 Mil mean?
Becton Dickinson (BDX) has a Other Current Receivables of $0 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Other Current Receivables too high?
Becton Dickinson's current Other Current Receivables is $0 Mil. Overall, Becton Dickinson has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Other Current Receivables compare to MDLN and RMD?
Becton Dickinson's Other Current Receivables of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Other Current Receivables is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (BDX) is currently considered Modestly Undervalued. The stock's GF Value™ is $191.05, compared to a current price of $151.38 — trading 20.8% below its estimated fair value. The current Other Current Receivables is $0 Mil. Becton Dickinson's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Becton Dickinson (BDX), the current Other Current Receivables is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of $151.38 is trading 20.8% below its estimated GF Value™ of $191.05. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for BDX:

  • Other Current Receivables: $0 Mil
  • GF Value™: $191.05 vs. price of $151.38 (20.8% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
76GF Score

Get the complete analysis for BDX

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$151.38
Price
$191.05
GF Value